APA (7th ed.) Citation

Llaneras, J., Riveiro-Barciela, M., Lens, S., Diago, M., Cachero, A., García-Samaniego, J., . . . Llerena, S. (2019). Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs. Journal of Hepatology, 71(4), 666. https://doi.org/10.1016/j.jhep.2019.06.002

Chicago Style (17th ed.) Citation

Llaneras, Jordi, et al. "Effectiveness and Safety of Sofosbuvir/velpatasvir/voxilaprevir in Patients with Chronic Hepatitis C Previously Treated with DAAs." Journal of Hepatology 71, no. 4 (2019): 666. https://doi.org/10.1016/j.jhep.2019.06.002.

MLA (9th ed.) Citation

Llaneras, Jordi, et al. "Effectiveness and Safety of Sofosbuvir/velpatasvir/voxilaprevir in Patients with Chronic Hepatitis C Previously Treated with DAAs." Journal of Hepatology, vol. 71, no. 4, 2019, p. 666, https://doi.org/10.1016/j.jhep.2019.06.002.